Chemoinformaics analysis of Phlogacanthollides B
| Molecular Weight | 332.44 | nRot | 1 |
| Heavy Atom Molecular Weight | 304.216 | nRig | 21 |
| Exact Molecular Weight | 332.199 | nRing | 4 |
| Solubility: LogS | -4.511 | nHRing | 1 |
| Solubility: LogP | 3.321 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 55.2782 |
| nHD | 2 | BPOL | 30.6938 |
| QED | 0.819 |
| Synth | 4.622 |
| Natural Product Likeliness | 2.381 |
| NR-PPAR-gamma | 0.076 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.093 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.692 |
| MDCK | 0.0000205 |
| BBB | 0.193 |
| PPB | 0.977232 |
| VDSS | 1.495 |
| FU | 0.0343343 |
| CYP1A2-inh | 0.247 |
| CYP1A2-sub | 0.774 |
| CYP2c19-inh | 0.04 |
| CYP2c19-sub | 0.791 |
| CYP2c9-inh | 0.265 |
| CYP2c9-sub | 0.243 |
| CYP2d6-inh | 0.043 |
| CYP2d6-sub | 0.588 |
| CYP3a4-inh | 0.289 |
| CYP3a4-sub | 0.306 |
| CL | 16.066 |
| T12 | 0.171 |
| hERG | 0.005 |
| Ames | 0.034 |
| ROA | 0.753 |
| SkinSen | 0.241 |
| Carcinogencity | 0.195 |
| EI | 0.016 |
| Respiratory | 0.975 |
| NR-Aromatase | 0.889 |
| Antiviral | Yes |
| Prediction | 0.582585 |